| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |